Objectives: This study was conducted to evaluate the prognostic value of, respectively, the 6th and 7th editions of the American Joint Committee on Cancer (AJCC) staging system for patients with resected perihilar cholangiocarcinoma (PHC).
INTRODUCTION
Perihilar cholangiocarcinoma (PHC) accounts for about 60% of all cases of cholangiocarcinoma and has an annual incidence of one to two cases per 100 000 population. It involves the occurrence of tumors at or near the biliary confluence, arising between the origin of the cystic duct and the confluence of the second-order bile ducts. 1 Tumors arising distal to the origin of the cystic duct are classified as lesions of distal cholangiocarcinoma, and tumors that are proximal to the left and right hepatic ducts are classified as lesions of intrahepatic cholangiocarcinoma. Patients with PHC typically present with symptoms arising from bile duct obstruction. Resection is the optimal treatment and facilitates a median overall survival (OS) of about 44 months. 2 Unfortunately, at presentation the majority of patients has metastatic or locally advanced disease and consequently do not benefit from resection.
Several systems for staging PHC have been published. The Bismuth classification and the Blumgart T-stage focus on determining resectability using preoperative imaging. 3, 4 DeOliveira et al. recently introduced a new classification for PHC, including both radiologic and pathologic covariates. 5 This classification is comprehensive, but remains to be validated. The American Joint Committee on Cancer (AJCC) staging still represents the staging system most widely used to determine prognosis and appropriate treatment, and to compare outcomes among centres.
In the 6th edition (2003) of the AJCC staging system, all patients with extrahepatic bile duct tumors were covered by a single classification. 6 In the 7th edition (2010), perihilar (proximal) and distal cholangiocarcinoma were staged separately. 1 Two important changes from the 6th to 7th editions for PHC concern the definitions of T-stage (Table 1) . Firstly, invasion of the liver parenchyma was downstaged to stage T2b in the 7th edition from stage T3. Secondly, T4 was expanded to include the bilateral involvement of second-order bile ducts (Bismuth 4) , and the unilateral involvement of second-order bile ducts and contralateral vascular involvement. With respect to N-stage, N2 was introduced as a new N-stage for metastases to lymph nodes beyond those in the hepatoduodenal ligament, including the periaortic and pericaval lymph nodes and those at the superior mesenteric artery or the coeliac artery.
Other changes concerned the distribution of T-and N-stages across the stage groups. The objective of this study was to compare the prognostic accuracy of the 6th and 7th editions of the AJCC staging system in patients with resected PHC. Secondly, alternative stage distributions were evaluated to improve on the current AJCC staging.
METHODS

Patient population
This study included patients for whom prospective data had been collected in databases at two centers:
the Academic Medical Centre (AMC) in Amsterdam, the Netherlands, and the Memorial Sloan-Kettering
Cancer Center (MSKCC) in New York, USA. The institutional review boards of each center approved the study. Consecutive patients with resected PHC were included. Perihilar cholangiocarcinoma was defined as cancer arising from the common hepatic duct (i.e. arising proximal to the origin of the cystic duct), biliary confluence, or main hepatic ducts (left or right) up to the confluence of the second-order bile ducts. Patients with papillary PHC and carcinoma in situ were also included. The study exclusion criteria excluded patients with final pathology indicative of a diagnosis other than PHC, patients who suffered in-hospital mortality, patients who underwent an R2 resection, and patients submitted to reresection after initial resection in another hospital. Data on patient demographics, laboratory studies, preoperative imaging, preoperative biliary drainage, type of surgery, pathology and OS were collected. 
Patient management
Preoperative workup and patient selection for surgery were similar in both centres. Patients typically underwent cross-sectional imaging with computed tomography (CT) of the chest, abdomen and pelvis and magnetic resonance cholangiopancreatography (MRCP) of the liver at or before initial referral, ideally prior to biliary drainage. Imaging allowed for evaluation of distant metastases, the biliary extent of the tumor, and involvement of the portal vein and hepatic artery.
In recent years, preoperative biliary drainage of the presumed remnant liver was carried out percutaneously rather than endoscopically in order to minimize the bacterial contamination of the biliary tract. However, many patients had undergone endoscopic drainage before referral. A brush was typically performed at the time of preoperative biliary drainage. However, pathologic confirmation of malignancy was not required to proceed with surgical resection. Diagnostic laparoscopy to rule out distant metastatic disease was performed often, but not in all patients,
given the decreasing yield as preoperative imaging improved over time. 7 With some exceptions, patients with involvement of the main portal vein, the portal vein bilaterally, the common hepatic artery or the hepatic artery bilaterally were considered unresectable. Patients with involvement of the second-order bile ducts were considered resectable if clear margins at the segmental bile ducts were anticipated. Fewer than 5% of all patients underwent preoperative portal vein embolization if the size and function of the future liver remnant were considered to be insufficient.
Fewer than 5% of all patients underwent neoadjuvant therapy. Table 2 presents the AJCC staging classification for both the 6th and 7th editions. Tumor stage was determined based on macroscopic and microscopic evaluations of the resected specimen. Evaluation of the biliary extent of the tumor was necessary to determine T4 stage in the 7th edition of the AJCC staging system. In fewer than 5% of patients, preoperative cross-sectional imaging was used if the pathology report was insufficiently detailed to determine the biliary extent of the tumor: isolated second-order biliary bile ducts were considered to be involved by the tumor. Evaluation of the vascular involvement of the tumor (portal vein or hepatic artery) was necessary to determine stages T3 and T4 according to both editions. In fewer than 5% of all patients, preoperative cross-sectional imaging was used if the pathology report was insufficiently detailed to determine vascular involvement: the portal vein and hepatic artery were considered to be involved in cases of occlusion, obvious narrowing or tumor abutment of ≥180 degrees.
Staging
Alternative tumor-node-metastasis stage groupings
Two regroupings of tumor-node-metastasis (TNM) stages were compared across the 6th and 7th
editions of the AJCC staging system. A regrouping of TNM stages was recently proposed by a Japanese multicenter study (Ebata staging). 8 In this staging system, bilateral second-order bile duct involvement (Bismuth 4) was removed from the T4 definition. Moreover, T4N0 patients were downstaged to stage IIIb, and TanyN1 patients were upstaged to stage IVa.
An alternative simplified regrouping of TNM stages was evaluated with only four stages: stage I represented disease that was confined to the bile duct (T1N0); stage II represented disease that extended beyond the bile duct (T2-4N0); stage III represented node-positive disease (TanyN1), and stage IV represented disease that included N2 nodes or distant metastasis (TanyN2 or TanyNanyM1).
Statistical analyses
Statistical analyses were performed using IBM spss Statistics for Windows Version 21.0 (IBM Corp., Armonk, NY, USA) and R (a language and environment for statistical computing) Version 3.0.2 for Mac (R Foundation for Statistical Computing, Vienna, Austria). Survival was measured from the date of surgery to the date of death or date of last contact prior to 1 January 2014. Survival probabilities were estimated using the Kaplan-Meier method and compared with the log-rank test. Overall survival was the primary outcome.
The concordance index and Brier score were used to compare the staging systems. 9 The concordance index is a measure of discrimination used to evaluate whether a staging system can discriminate between two patients at different stages of disease. It is calculated as the probability that for a random pair of patients at different stages of the disease, the patient at the lower stage has a longer observed survival. A concordance index of 0.5 means that the predictive ability is no better than guessing; a concordance index of 1 means perfect prediction. Other AJCC staging systems were found to have a concordance index of about 0.70. 10 When stage-specific survival is consistently higher or lower than the observed survival, this would be expected to remain undetected by the concordance index. Therefore, the Brier score is often used in combination with 
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RESULTS
Patients
A total of 306 consecutive patients submitted to surgery between 1991 and 2012 were identified.
These included: 133 (43.5%) patients at AMC and 173 (56.5%) patients at MSKCC. No patients were excluded for missing data on staging. Patient characteristics are summarized in Table 3 .
Median OS was 40 months (95% confidence interval: 34-46 months). A total of 103 patients (33.7%)
were censored at a median follow-up time of 38 months. Table 4 is a cross-tabulation presenting transitions for T-stages, N-stages and AJCC stages for the 6th and 7th staging editions. Table 6 presents the concordance indices and Brier scores for all evaluated staging systems.
Stage transitions
Survival across stages
Prognostic accuracy
Prognostic accuracy was remarkably similar across the AJCC staging systems. Expanding the 6th edition of the AJCC staging system with sub-stages did not improve prognostic accuracy; the 7th edition improved with sub-stages but its prognostic accuracy was similar to that of the 6th edition.
The prognostic accuracy of both the Ebata staging system and the alternative staging system was similar to that of the AJCC staging systems. 
DISCUSSION
This study compared the 6th and 7th editions of the AJCC staging system in patients with resected PHC using prospective databases from two centres. The log-rank P-value across all sub-stages was highly statistically significant for both the 6th and 7th editions (P < 0.001). Prognostic accuracy was similar for both editions, with a concordance index of 0.59 and a Brier score of 0.17. The same A study from Germany previously compared the 6th and 7th editions of the AJCC system. A study from Japan evaluated the 7th edition of the AJCC staging system and found that patients with T4 tumors (stage IVa) had better survival than patients with regional node-positive disease (stage IIIb), a finding confirmed in the present study. 8 They proposed a modified staging system that was considered superior based on a higher chi-squared value. Validation using the data in the present study found the prognostic accuracy of this modified staging system to be similar to that of the 6th and 7th editions of the AJCC staging system ( Table 6 , Ebata staging). However, a higher proportion of patients in the Japanese series with Bismuth 4 or involvement of the main portal vein may have caused suboptimal validation.
The present study has several limitations. Firstly, this study is one of the largest Western series of patients with resected PHC (n = 306) to be reported in the literature, but its sample size is still insufficient to allow for the drawing of definitive conclusions about small modifications in the staging system. Secondly, this study included only resected patients. The advantage of this is that pathological confirmation of the TNM stage was available for all patients. The disadvantage is that the results cannot be extrapolated to patients who do not undergo resection because of distant metastasis or locally advanced disease. Only resected patients were included in this study because the assessment of both T-stage and N-stage is inaccurate without microscopic evaluation of the resected specimen. The evaluation of N-stage based on size cri-teria on cross-sectional imaging has been shown to be very inaccurate: only 37% of lymph nodes of >3 cm in diameter were found to be positive. 12 Thirdly, in the present series, relatively few patients showed involvement of the main portal vein or common hepatic artery that required vascular resection and reconstruction.
Centers around the world disagree about resectability criteria for patients with PHC. Some centers have published higher resection rates for patients with main or bilateral portal vein involvement. 13, 14 Consequently, OS in stage IV patients in the present study differs from that in stage IV patients reported in studies that include more stage T4 patients.
The differences in prognostic accuracy between staging systems were very small ( Table 6) , which is not uncommon when comparing staging systems. The concordance index was 0.59 and the Brier score 0.17 for both the 6th and the 7th edition. The prognostic accuracy of both staging systems was modest, as compared to other cancers such as gastric cancer. 10 Accuracy may have been better if disease-specific survival or recurrence-free survival instead of overall survival were used as primary outcome of the analyses. The proposed alternative staging is a simplified regrouping of TNM stages that could be considered for the next AJCC staging edition. However, the present study only considered patients who underwent resection.
Historically, the AJCC staging is based mainly on the anatomic extent of the tumor. Although non-anatomic factors have been introduced into the staging of some cancers (e.g. mitotic rate in 
